97 related articles for article (PubMed ID: 29307261)
1. High inducible nitric oxide synthase in prostate tumor epithelium is associated with lethal prostate cancer.
Erlandsson A; Carlsson J; Andersson SO; Vyas C; Wikström P; Andrén O; Davidsson S; Rider JR
Scand J Urol; 2018 Apr; 52(2):129-133. PubMed ID: 29307261
[TBL] [Abstract][Full Text] [Related]
2. Inducible nitric oxide synthase (iNOS) expression and its prognostic value in prostate cancer.
Aaltoma SH; Lipponen PK; Kosma VM
Anticancer Res; 2001; 21(4B):3101-6. PubMed ID: 11712818
[TBL] [Abstract][Full Text] [Related]
3. Inducible nitric oxide synthase expression in benign prostatic hyperplasia, low- and high-grade prostatic intraepithelial neoplasia and prostatic carcinoma.
Baltaci S; Orhan D; Gögüs C; Türkölmez K; Tulunay O; Gögüs O
BJU Int; 2001 Jul; 88(1):100-3. PubMed ID: 11446856
[TBL] [Abstract][Full Text] [Related]
4. [The apoptosis and its relationship with the expression of inducible nitric oxide synthase and Bcl-2 proteins in prostate carcinoma].
Xu M; Li S; Zheng X; Hu L
Zhonghua Nan Ke Xue; 2004 Jan; 10(1):39-41. PubMed ID: 14979207
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of inducible nitric oxide synthase in local prostate cancer.
Aaltomaa SH; Lipponen PK; Viitanen J; Kankkunen JP; Ala-Opas MY; Kosma VM
BJU Int; 2000 Aug; 86(3):234-9. PubMed ID: 10930922
[TBL] [Abstract][Full Text] [Related]
6. M2 macrophages and regulatory T cells in lethal prostate cancer.
Erlandsson A; Carlsson J; Lundholm M; Fält A; Andersson SO; Andrén O; Davidsson S
Prostate; 2019 Mar; 79(4):363-369. PubMed ID: 30500076
[TBL] [Abstract][Full Text] [Related]
7. Selective expression of inducible nitric oxide synthase in human prostate carcinoma.
Klotz T; Bloch W; Volberg C; Engelmann U; Addicks K
Cancer; 1998 May; 82(10):1897-903. PubMed ID: 9587122
[TBL] [Abstract][Full Text] [Related]
8. Neuronal and inducible nitric oxide synthase expression in the rat cerebellum following portacaval anastomosis.
Suárez I; Bodega G; Rubio M; Felipo V; Fernández B
Brain Res; 2005 Jun; 1047(2):205-13. PubMed ID: 15904901
[TBL] [Abstract][Full Text] [Related]
9. High iNOS and IL-1β immunoreactivity are features of colitis-associated colorectal cancer tumors, but fail to predict 5-year survival.
Björner K; Chen WN; Gannavarapu VR; Axling F; Gulyas M; Halim MA; Webb DL; Hellström PM
Ups J Med Sci; 2023; 28():. PubMed ID: 38187473
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in prostate cancer.
Stattin P
Scand J Urol Nephrol Suppl; 1997; 185():1-46. PubMed ID: 9249905
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide-mediated inhibition of androgen receptor activity: possible implications for prostate cancer progression.
Cronauer MV; Ince Y; Engers R; Rinnab L; Weidemann W; Suschek CV; Burchardt M; Kleinert H; Wiedenmann J; Sies H; Ackermann R; Kröncke KD
Oncogene; 2007 Mar; 26(13):1875-84. PubMed ID: 16983333
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional regulation of inducible nitric oxide synthase gene therapy: targeting early stage and advanced prostate cancer.
Coulter JA; Page NL; Worthington J; Robson T; Hirst DG; McCarthy HO
J Gene Med; 2010 Sep; 12(9):755-65. PubMed ID: 20821746
[TBL] [Abstract][Full Text] [Related]
13. Inducible nitric oxide synthase expression and its prognostic significance in colorectal cancer.
Zafirellis K; Zachaki A; Agrogiannis G; Gravani K
APMIS; 2010 Feb; 118(2):115-24. PubMed ID: 20132175
[TBL] [Abstract][Full Text] [Related]
14. Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer.
Preston MA; Batista JL; Wilson KM; Carlsson SV; Gerke T; Sjoberg DD; Dahl DM; Sesso HD; Feldman AS; Gann PH; Kibel AS; Vickers AJ; Mucci LA
J Clin Oncol; 2016 Aug; 34(23):2705-11. PubMed ID: 27298404
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of the Long Non-coding RNA SChLAP1 Independently Predicts Lethal Prostate Cancer.
Mehra R; Udager AM; Ahearn TU; Cao X; Feng FY; Loda M; Petimar JS; Kantoff P; Mucci LA; Chinnaiyan AM
Eur Urol; 2016 Oct; 70(4):549-552. PubMed ID: 26724257
[TBL] [Abstract][Full Text] [Related]
16. High Lysyl Oxidase (LOX) in the Non-Malignant Prostate Epithelium Predicts a Poor Outcome in Prostate Cancer Patient Managed by Watchful Waiting.
Nilsson M; Hägglöf C; Hammarsten P; Thysell E; Stattin P; Egevad L; Granfors T; Jernberg E; Wikstrom P; Halin Bergström S; Bergh A
PLoS One; 2015; 10(10):e0140985. PubMed ID: 26501565
[TBL] [Abstract][Full Text] [Related]
17. High density of S100A9 positive inflammatory cells in prostate cancer stroma is associated with poor outcome.
Tidehag V; Hammarsten P; Egevad L; Granfors T; Stattin P; Leanderson T; Wikström P; Josefsson A; Hägglöf C; Bergh A
Eur J Cancer; 2014 Jul; 50(10):1829-1835. PubMed ID: 24726733
[TBL] [Abstract][Full Text] [Related]
18. Lack of inducible nitric oxide synthase in bronchial epithelium: a possible mechanism of susceptibility to infection in cystic fibrosis.
Meng QH; Springall DR; Bishop AE; Morgan K; Evans TJ; Habib S; Gruenert DC; Gyi KM; Hodson ME; Yacoub MH; Polak JM
J Pathol; 1998 Mar; 184(3):323-31. PubMed ID: 9614386
[TBL] [Abstract][Full Text] [Related]
19. Expression of inducible nitric oxide synthase in tumoral and non-tumoral epithelia from bladder cancer patients.
Sandes EO; Faletti AG; Riveros MD; Vidal Mdel C; Gimenez L; Casabé AR; Eiján AM
Nitric Oxide; 2005 Feb; 12(1):39-45. PubMed ID: 15631946
[TBL] [Abstract][Full Text] [Related]
20. Inducible nitric oxide synthase expression is upregulated in oral submucous fibrosis.
Rajendran R; Varkey S
Indian J Dent Res; 2007; 18(3):94-100. PubMed ID: 17687170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
